-
1
المؤلفون: Saskia Biskup, Felix Behling, Marcos Tatagiba, Christian la Fougère, Florian H. Ebner, Frank Paulsen, Kathrin Machetanz, Martin Korn, Ulrike Ernemann, Praveen Baskaran, Juergen Honegger, Sven Nahnsen, Ghazaleh Tabatabai, Jens Schittenhelm, Irina Gepfner-Tuma, Marco Skardelly
مصطلحات موضوعية: Cancer Research, Pathology, medicine.medical_specialty, business.industry, MTOR Serine-Threonine Kinases, medicine.disease, Discovery and development of mTOR inhibitors, Meningioma, Abstracts, Oncology, medicine, Neurology (clinical), Akt1 gene, business, Exome, Exome sequencing
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fdae364a9e16eb06c915a4691c2e85cTest
https://europepmc.org/articles/PMC6217318Test/ -
2
المؤلفون: Naina L. Gross, Wafik Zaky, Rene Y. McNall-Knapp, Theresa Gavula, Benjamin O. Cornwell, Abhishek Bavle
المصدر: Neuro-Oncology
مصطلحات موضوعية: Cancer Research, Pathology, medicine.medical_specialty, Pilocytic astrocytoma, Rosette (schizont appearance), business.industry, Obstructive hydrocephalus, Low Grade Glioma, Fourth ventricle, Discovery and development of mTOR inhibitors, medicine.disease, Systemic therapy, Oncology, Glioneuronal tumor, Medicine, AcademicSubjects/MED00300, AcademicSubjects/MED00310, Neurology (clinical), Periumbilical pain, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::596b9689f379d92a32a0d3ab37a3a160Test
http://europepmc.org/articles/PMC7715392Test -
3
المؤلفون: Hisato Igarashi, Chigusa Morizane, Tetsuhide Ito, Yoshie Fujita, Kohei Nakachi, Takeshi Tajima, Akio Kasuga, Masafumi Ikeda, Junji Furuse, Takuji Okusaka
المصدر: Japanese Journal of Clinical Oncology
مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, mTOR inhibitors, Subgroup analysis, Placebo, Gastroenterology, law.invention, Young Adult, Randomized controlled trial, Double-Blind Method, law, Internal medicine, medicine, Clinical endpoint, Humans, Radiology, Nuclear Medicine and imaging, Clinical Trials, Everolimus, Aged, Neoplasm Staging, Randomized Controlled Trials as Topic, Aged, 80 and over, Sirolimus, Japanese population, business.industry, Hazard ratio, General Medicine, Original Articles, Middle Aged, Prognosis, Rash, pancreatic neuroendocrine tumours, Confidence interval, Surgery, Pancreatic Neoplasms, Survival Rate, Neuroendocrine Tumors, Oncology, Clinical Trials, Phase III as Topic, Female, medicine.symptom, business, Immunosuppressive Agents, medicine.drug, Follow-Up Studies
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bcb4dce6b017400df19f8691e9dfc05Test
http://europepmc.org/articles/PMC3448379Test